Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation (Tables)

v3.23.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Stock-based Compensation Expense
The stock-based compensation expense attributable to continuing operations is included in the consolidated statements of operations and comprehensive loss as indicated in the table below. Effective January 1, 2022, the Company reorganized its captions on the consolidated statements of operations and comprehensive loss to better align the Company’s broad portfolio. As a result, for the year ended December 31, 2021, the amounts presented to reflect the impact of the reorganization have been recasted. This resulted in a $2.3 million reclassification of stock compensation expense between imagery & software analytical service costs, excluding depreciation and amortization and professional & engineering service costs, excluding depreciation and amortization in the Company's consolidated statements of operations and comprehensive loss.
Years Ended December 31,
2022 2021
(in thousands)
Imagery & software analytical service costs, excluding depreciation and amortization $ 553  $ 1,824 
Professional & engineering service costs, excluding depreciation and amortization 1,341  2,297 
Selling, general and administrative 18,131  38,450 
Total stock-based compensation expense $ 20,025  $ 42,571 
Schedule of Share-based Payment Arrangements, Stock Options, Valuation Assumptions A summary of the weighted-average assumptions used by the Company is presented below:
Years Ended December 31,
2022 2021
Fair value per common share
$2.06 - $2.15
$ 5.40 
Weighted-average risk-free interest rate
3.20% - 4.72%
1.44  %
Volatility
33.90% - 41.10%
33.40  %
Expected term (in years) 7.63 8.00
Dividend rate % %
Share-based Payment Arrangement, Option, Activity
A summary of the Company’s stock option activity under the Plans during the year ended December 31, 2022 is presented below:
Options Weighted-Average Exercise Price Weighted Average Contractual Term Aggregate Intrinsic Value
(in thousands) (in years) (in thousands)
Outstanding - January 1, 2022 5,022  $ 4.49 
Granted 5,305  2.14 
Exercised (709) 0.07 
Forfeited (977) 7.21 
Outstanding - December 31, 2022 8,641  3.10  8.68 $ 1,868 
Exercisable - December 31, 2022 1,898  2.73  6.15 1,333
Nonvested Restricted Stock Shares Activity
A summary of the Company’s nonvested RSA activity during the year ended December 31, 2022 is presented below:
Restricted Stock Awards Weighted-Average Grant-Date Fair Value
(in thousands)
Nonvested - January 1, 2022 335  $ 0.01 
Vested (200) 0.01 
Canceled (78) 0.01 
Nonvested - December 31, 2022 57  0.01 
Share-based Payment Arrangement, Restricted Stock Unit, Activity
A summary of the Company’s nonvested RSU activity during the year ended December 31, 2022 is presented below:
Restricted Stock Units Weighted-Average Grant-Date Fair Value
(in thousands)
Nonvested - January 1, 2022 10,959  $ 6.77 
Granted 4,558  2.06 
Vested (6,728) 6.92 
Canceled (935) 5.36 
Nonvested - December 31, 2022 7,854  4.08